Company / Operating Income per Share
Kura Oncology, Inc. Operating Income per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.88
FY2025
5-year range
-$3.88 / -$2.09
FY2022-FY2025
Trend
-49.4%
vs FY2024
Sector context
#159 of 201
Health Care
What the data says
Kura Oncology, Inc.'s operating income per share of $-3.88 is lower than 79% of companies in the Health Care sector (FY2025). Operating Income per Share has declined for 3 consecutive years, from $-2.09 in FY2022 to $-3.88 in FY2025.
Based on SEC 10-K filings.
-3.88 in FY2025.
Declined from $-2.26 to $-3.88 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 201This company -$3.88 Sector average -$28.56
▼
+86.4% above sector average
Key checks
Key Insights
- Kura Oncology, Inc.'s operating income per share has declined for 3 consecutive years.
- In FY2025, operating income per share decreased 49.4% year-over-year.
- Ranks #159 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.88 | -49.4% |
| FY2024 | -$2.60 | -14.8% |
| FY2023 | -$2.26 | -8.4% |
| FY2022 | -$2.09 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026